Although I enrolled in the midst of Covid-19, which was not the most favorable timing, my three years journey in IMU was undoubtedly enriching and fruitful.
One of the most palpable predicaments I had encountered was to keep up with the dynamic online learning during the global pandemic. I was apprehensive at first as my previous experience with hybrid learning did not get me excited about the prospect of doing it again. However, I went ahead and accepted the new norm, and I did not regret it at all. Upon getting accustomed to it, I found online learning to be similar to physical learning as all it takes is merely self-discipline. Although I was unable to direct questions face-to-face, my lecturers are always willing to lend a hand to clarify my doubts.
One of the reasons that contributed to my decision of pursuing my tertiary education at IMU is due to the well-rounded course structure. It has always been my dream to study in a top university, what’s more a long-established university with a dedicated focus to healthcare education.
Although my course is a chemistry-focused programme, it also provides other biological relevant modules including pharmacokinetics, pharmacology, pharmaceutics, and human biology. We are also given the opportunity to learn biotechnology-based modules as well as pharmaceutical engineering, bioinformatics and mathematics and statistics, which are crucial fundamental knowledge related to the pharmaceutical industry.
The course structure has also equipped us with the necessary soft skills, including research, problem solving and analytical skills. All these modules have given me in-depth understanding and knowledge in drug discovery and development process, including the formulation and reaction between drugs and human bodies.